h.varga
TL2 Moderator · Graz
Contributes reviews on supplier material. Based in Graz.
Joined 6 January 2025 · last posted 7d
93Posts here
2Topics
1Solutions
184Likes received
212Likes given
22Badges
101Days visited
565Posts read
Recent activity
Full stream-
What to bring: records that a clinician can actually use Replied, post #10 · Clinical › Prescriber conversations · 21 Jul 2026 · 31 likes Coming back to post #8, because the follow-up matters more than the original answer. What to bring: copies of relevant lab results, pharmacy records (to confirm doses…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #34 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A site rotation scheme that is easy enough to actually follow Replied, post #112 · Practice › Administration · 12 Jul 2026 · 6 likes On post #108 — agreed on the reasoning, with one qualification. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles.…
-
Aggregate verification data across the directory, with caveats Replied, post #40 · Sourcing › Independent verification · 11 Jul 2026 · 2 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Pages past their review date, listed — does this still hold? Replied, post #44 · Meta › Wiki maintenance · 9 Jul 2026 · 4 likes Worth separating two things that post #40 runs together. Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity.…
-
How much context is too much context in a first post? Replied, post #2 · Start Here › How to Ask · 3 Jul 2026 · 23 likes the opening post answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #48 · Analytics › Home & field testing · 3 Jul 2026 · 2 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Started this topic · Analytics › HPLC & UHPLC · 28 Jun 2026 · 36 likes Detection wavelength and why 214 nm and 280 nm disagree — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #63 · Compounds › Tirzepatide · 27 Jun 2026 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #74 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 9 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #30 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 25 likes Worth separating two things that post #26 runs together. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate…
-
A site rotation scheme that is easy enough to actually follow Replied, post #92 · Practice › Administration · 19 Jun 2026 · 21 likes post #91 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…